That beam of light
Release time:
2020-07-22
The beam of light
Love is like fickle weather, with blue sky and white clouds and clear sky and stormy weather. The relationship that lasted for six years suddenly ended, making me feel like I lost my soul and was once very depraved, and she, like a beam of light, broke into my life off guard and lit up my dark inner world.
The first contact with her was purely accidental, just a simple gathering of colleagues. When I first saw her, I was not familiar with her and I was not excited. It was a very dull feeling. In fact, at that time, I didn't have anyone I knew very well in the company. I stayed alone in the dormitory every day after work. Some people may think that I am a careless person, but in fact, I just used to hide everything I see in my heart. With the passage of time, gradually, I saw her optimistic, cheerful, upward, strong; on the other hand, she is almost the opposite.
The time when I rehearsed the dance for the "60th Anniversary of Entrepreneurship" celebration was the time when I had the most contact with her. During a rehearsal, her foot was injured and swollen badly because of a difficult movement. At one point I thought she was quitting the dance team. But the next day, she still limped to the rehearsal site. During the rehearsal, her dancing was still so graceful, but from the big beads of sweat on her forehead, you can see how much pain she was suffering. A girl with a weak appearance, but a strong heart!
During the more than one month of rehearsing the dance, I changed a lot, became optimistic, became strong, and became hardworking. I don't know why, I just feel that my heart has been shot into a beam of light, dispelling the haze that has been shrouded for a long time. I began to reflect on my day's gains and losses, thinking about how I can become better, and how I should go in the future.
I began to follow her, making myself as good as her, working hard and attentively every day, insisting on sitting at the window of the dormitory like her to read after work every day, expanding my knowledge, insisting on writing articles every month to exercise my literary talent, and studying hard her behavior... Because I realized that she was my light.
In March of another year, she left the company. But for me, this is not a traditional parting, because I can still see her, and she is only my own beam of light. (Liu Xiaojian)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31